CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Tysabri ® (Natalizumab)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01455220
NCT01455220N/ACompleted
CompareCT.gov

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

University of South Florida·interventional·Posted Oct 19, 2011·Updated Mar 31, 2017

In Brief

A clinical study evaluating Tysabri ® (Natalizumab) for Multiple Sclerosis. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if sexual dysfunction symptoms and quality of life measures in patients with Multiple Sclerosis may be improved in patients that are prescribed Tysabri.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2011
Enrollment StartJan 1, 2011
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.7 years ago

Interventions

Tysabri ® (Natalizumab)drug

IV, monthly